The Pharmacovigilance Risk Assessment Committee recently identified Capillary leak syndrome and small-vessel vasculitis as the latest vaccine-related risks.
The European Medicines Agency (EMA) safety committee (PRAC) warns of further complications from the Moderna and Johnson & Johnson Covid “vaccines.” The EMA is an agency of the European Union in charge of the evaluation and supervision of medicinal products.
On March 11, 2022, in a meeting of the pharmacovigilance, new recommendations were made of which possible side effects should be added to the vaccine’s product information. It has now been recognized that Spikevax, Moderna’s mRNA vaccine, can cause an outbreak of what is known as capillary leak syndrome (CLS). The disease is described as follows:
CLS is an extremely rare, serious condition that causes fluid to leak from small blood vessels (capillaries), causing rapid swelling of the arms and legs, sudden weight gain, feeling faint, thickening of the blood, low levels of albumin in the blood (an important blood protein) and low blood pressure. CLS is commonly associated with viral infections, some blood cancers, inflammatory diseases, and some treatments…
